Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature

The choice between different fertility-sparing surgery procedures depends first on the oncologic issues. Fertility results should then be taken into consideration to select the best choice acceptable to the patient/couple.

Like Comment

Volume 106, Issue 5, Pages 1195-1211

Authors:

Enrica Bentivegna, M.D., Amandine Maulard, M.D., Patricia Pautier, M.D., Cyrus Chargari, M.D., Ph.D., Sebastien Gouy, M.D., Ph.D., Philippe Morice, M.D., Ph.D.

Abstract:

Objectives

To evaluate the fertility results, obstetric outcomes, and the management of infertility in patients submitted to fertility-sparing surgery (FSS) for invasive cervical cancer.

Design

Systematic review.

Setting

Not applicable.

Patient(s)

Patients submitted to FSS for invasive cervical cancer (stage IB).

Intervention(s)

Five different FSS procedures were studied.

Main Outcomes Measure(s)

Fertility, pregnancy outcomes, and management of infertility.

Result(s)

A total of 2,777 patients submitted to FSS and 944 ensuing pregnancies were included in this review. Five different surgical procedures were performed and studied. The overall fertility, live birth, and prematurity rates after these procedures were, respectively, 55%, 70%, and 38%. The pregnancy rate was higher in patients submitted to a vaginal or minimally invasive radical trachelectomy compared with a laparotomic radical trachelectomy. The live birth rate was similar, whatever the FSS procedure. The prematurity rate was significantly lower in patients who had undergone a simple trachelectomy/cone resection and neoadjuvant chemotherapy followed by FSS compared with conservative surgery. A majority of second trimester fetal losses and premature deliveries were related to premature rupture of membranes.

Conclusion(s)

The choice between the different FSS procedures depends first and foremost on the oncologic characteristics of the tumor. Nevertheless, when several options seem to offer the same oncologic results (for example, stage IB1 disease >2 cm), fertility results should then be taken into consideration to select the best choice acceptable to the patient/couple.


Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.